Compare Marsh & McLennan Companies, Inc. (MRSH) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Marsh & McLennan Companies, Inc. vs 10X Genomics Inc — how do they compare? Marsh & McLennan Companies, Inc. trades at $180.6 (market cap $87.77B), while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: Marsh & McLennan Companies, Inc. is far larger — about 16× 10X Genomics Inc's market cap, and Marsh & McLennan Companies, Inc. pays a 2.17% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| MRSH | TXG | |
|---|---|---|
Market Cap | $87.77B | $5.48B |
Sector | Financials | Health |
52-Week High | $211.21 | $45.80 |
52-Week Low | $157.32 | $11.34 |
Enterprise Value | $108.61B | $5.02B |
Dividend Yield | 2.17% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Marsh & McLennan Companies, Inc.
Marsh & McLennan Companies Inc is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (management and economic consultancy).
Read more on MRSH →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
